• iPSC-Derived Organoids Enable Multilineage HEV Modeling In V

  2026-05-22

  The referenced study establishes iPSC-derived human liver, intestinal, and brain organoids as robust models for propagating multiple hepatitis E virus (HEV) genotypes. This innovation provides a physiologically relevant platform for studying HEV pathogenesis and antiviral strategies, with implications for translational infectious disease research beyond traditional cell lines.

• Metabolite Regulation of TET2: Protocols for Enzyme Activity

  2026-05-22

  The reference study introduces a robust protocol combining biochemical assays and STD NMR spectroscopy to validate metabolite binding and regulatory effects on TET2 dioxygenase. This framework advances our understanding of how metabolic states influence epigenetic enzyme activity, with broad implications for cancer and metabolic research.

• BMS 599626 Dihydrochloride: Advancing EGFR/ErbB2 Inhibition

  2026-05-21

  Explore mechanistic insights and translational strategies for leveraging BMS 599626 dihydrochloride, a potent EGFR and ErbB2 inhibitor, in cancer and senescence research. This thought-leadership article bridges foundational oncogenic signaling science, robust experimental protocols, and strategic guidance for integrating APExBIO’s inhibitor into next-generation workflows, including AI-driven senolytic discovery.

• ABT-263 (Navitoclax): Practical Guidance for Apoptosis Assay

  2026-05-21

  ABT-263 (Navitoclax) is a potent, orally bioavailable Bcl-2 family inhibitor widely used to dissect caspase-dependent apoptosis in cancer biology research. It is optimal for in vitro and in vivo studies of Bcl-2, Bcl-xL, and Bcl-w-mediated survival pathways, but is not suitable for diagnostic or therapeutic applications. Correct solubilization and storage are essential for experimental reliability.

• Sulforaphane Mitigates PM2.5-Induced COPD via Nrf2 and EGFR/

  2026-05-20

  This study elucidates how sulforaphane (SFN) attenuates PM2.5-induced chronic obstructive pulmonary disease (COPD) by modulating Nrf2 activation and suppressing EGFR/PI3K/AKT signaling. The findings provide mechanistic insights into SFN's antioxidative and anti-inflammatory actions in environmentally triggered COPD, highlighting methodological advances for oxidative stress measurement in preclinical research.

• Cationic Lipid-Enriched LNPs Enhance Local mRNA Expression I

  2026-05-20

  This study systematically investigates how incorporating cationic lipids, particularly DOTAP, into lipid nanoparticle (LNP) formulations alters the biodistribution and immunogenicity of mRNA vaccines delivered intramuscularly. The findings reveal that modest DOTAP enrichment increases local protein expression and early IgG responses, offering insight into optimizing LNP design for targeted mRNA delivery.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-05-19

  This study presents an optimized protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs), overcoming key limitations of existing in vitro models for pharmacokinetic research. The work enables more reliable assessment of drug metabolism and absorption, with direct implications for drug discovery and β-adrenergic modulation studies.

• HyperScribe T7 High Yield RNA Synthesis Kit: Workflow & CRIS

  2026-05-19

  Unlock rapid, high-yield RNA synthesis for demanding applications such as CRISPR gene editing and RNA therapeutics with the HyperScribe T7 High Yield RNA Synthesis Kit. Discover protocol insights, troubleshooting strategies, and lessons from cutting-edge breast cancer research to maximize RNA quality and experimental efficiency.

• 10 mM dNTP Mixture: Precision and Trafficking in DNA Synthes

  2026-05-18

  Explore how the 10 mM dNTP mixture enables high-fidelity DNA synthesis and impacts intracellular nucleotide delivery. This article provides a unique perspective by integrating core biochemical parameters with new insights from lipid nanoparticle trafficking research.

• Nicotinamide Riboside Chloride (NIAGEN): Enabling Reproducib

  2026-05-18

  Explore how Nicotinamide Riboside Chloride (NIAGEN) drives reproducibility in metabolic dysfunction research and neurodegenerative disease models. This article uniquely analyzes assay design and practical integration strategies for NAD+ modulation, grounded in recent breakthroughs.

• Isoprinosine (SKU C4417): Reliable Immunomodulator for Viral

  2026-05-17

  This article provides a scenario-driven, evidence-based guide for biomedical researchers seeking reproducible immunomodulation and direct antiviral effects in cell-based assays. We examine Isoprinosine (inosine pranobex, SKU C4417) as supplied by APExBIO, focusing on its demonstrated reliability, workflow compatibility, and quantitative performance data relevant to viral infection models, including HHV-1. Practical insights and protocol parameters are integrated throughout for optimal experimental outcomes.

• T0070907: Nanomolar PPARγ Antagonist for Pathway Dissection

  2026-05-16

  T0070907 is a potent, selective PPARγ antagonist with 1 nM IC50, enabling high-precision inhibition of PPARγ signaling and adipogenesis. Its covalent mechanism disrupts coactivator binding and promotes corepressor recruitment, providing a robust tool for dissecting transcriptional repression and cell cycle effects. APExBIO supplies T0070907 (A4301) for advanced research applications in metabolic and cancer biology.

• Arachidonic Acid Supplementation Accelerates Vaccine Immunit

  2026-05-15

  This study demonstrates that dietary arachidonic acid (ARA) significantly enhances the speed and magnitude of humoral immune responses to rabies vaccination in both mice and humans. By elucidating the cAMP-PKA axis and prostaglandin I2 as key mediators, the research provides a mechanistic foundation for dietary fatty acid modulation as a strategy to improve vaccine efficacy.

• Dual-Function Anti-Inflammatory Stent Suppresses Tracheal Re

  2026-05-15

  A recent study by Zhao et al. introduces an airway stent integrating anti-inflammatory and anti-angiogenic agents, effectively reducing tracheal in-stent restenosis in a rabbit model. The stent addresses the overlooked issue of excessive vascularization and provides a new avenue for modulating the tracheal microenvironment to improve stent durability and patient outcomes.

• ISRIB (trans-isomer): Rewiring Memory Research via ISR Modul

  2026-05-14

  Discover how ISRIB (trans-isomer), a next-generation PERK inhibitor, is redefining translational memory research by bridging mechanistic insight and strategic experimental design. Drawing from recent molecular neurobiology findings, this article provides actionable guidance for ER stress research, highlights ISRIB’s unique advantages, and sets the agenda for future studies in cognitive enhancement and neurodegenerative disease models.

548 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page